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1. Introduction  
1.1 Nanoparticles 
Adverse health effects have been associated with the exposure to particulate matter (PM) 
ever since the London smog in the winter of 1952. Recent estimates attribute about 12,000 
excess deaths to have occurred because of acute and persisting effects of the London smog 
(Bell & Davis, 2001). Over the years a number of epidemiological studies have shown that 
PM from combustion sources such as motor vehicles contributes to respiratory and 
cardiovascular morbidity and mortality (Kreyling et al., 2002, 2006, Wick et al., 2010). 
Especially so do the ultra-fine particles (UFPs) with a diameter less than 0.1 micrometer. 
UFPs from combustion engines are capable to translocate over the alveolar–capillary barrier 
(Rothen-Rutishauser et al., 2007). When nano-sized PM (nanoparticles, NP), which are small 
enough to enter the blood stream, do so they are likely to interact with plasma proteins and 
this protein-NP interaction will probably affect the fate of and the effects caused by the NPs 
in the human body. Herein we present results showing that several proteins indeed are 
associated to NPs that have in vitro been introduced to human blood plasma.  
NPs are atoms and molecules defined as particles less than 100 nanometers in at least one 
dimension (Elsaesser & Howard, 2011). Due to the plethora of NPs being produced in 
various forms (e.g. spherical, fibers, rods, clusters) or by different processes (e.g. flame-
spray synthesis, chemical vapor deposition), defining the characteristics of a NP is not an 
easy task even when it comes to manufactured NPs and when considering those formed 
unintentionally during processes such as combustion in motor vehicles it becomes an even 
harder task. This variation in properties according to the respective composition of NPs is 
also the basis of the wide range of potential applications, from medicine to consumer 
products. Due to the unique physicochemical properties of nanomaterials, there are plenty 
of possibilities for NPs to enter the human body, either deliberately as medicines or 
unintentionally as environmental contaminants and thus potentially cause adverse human 
health effects (Elsaesser & Howard, 2011; Stern & McNeil, 2008). Although many 
characteristics have been highlighted as driving the potential adverse health effects 
associated with NP exposure, it has been specifically the size and increased surface area of 
NPs that has been concluded as elucidating any such adverse effects observed (Elsaesser & 
Howard, 2011; Stern & McNeil, 2008). 
www.intechopen.com
 Gel Electrophoresis – Advanced Techniques 
 
328 
UFPs from combustion sources, such as motor vehicles, are capable to promote 
atherosclerosis, thrombogenesis and other cardiovascular events mainly via the ability to 
induce inflammatory and protrombotic responses (McAuliffe & Perry 2007). Thus,  
NP induced effects within the lung has been studied over the past twenty years (Mühlfeld et 
al., 2008; Rothen-Rutishauser et al., 2007). Indeed, exposure to most forms of NPs will 
initially be via inhalation, especially when considering occupational exposure, and thus will 
affect the respiratory system. The respiratory system is by far the main port of entry  
even though the gut and skin are also possible ways of entry.  However, NP localization  
and fate is not only restricted to their portal of entry. NPs can be distributed to organs distal 
to their site of exposure, so that potential NP toxicity can occur in any secondary  
site. Research into the possible secondary toxicity of NPs is quite limited. Even so  
studies investigating the effects of NP translocation to secondary organs have shown  
that NPs can elicit negative effects to the liver, brain, GI tract (following inhalation),  
spleen, reproductive systems and the placenta (Kreyling et al., 2002, 2006;  McAuliffe 
& Perry 2007; Wick et al., 2010). NPs toxic mechanisms at the cellular level includes  
protein misfolding and protein fibrillation  causing major problems in the brain and  
chronic inflammation as a result of nanoparticle exposure, for example in the lung and  
other organs, via frustrated phagocytosis or production of reactive oxygen species.  
A vulnerable target for possible toxicological effects of nanoparticles is the fetus.  
Gold nanoparticles have been shown to cross the maternal-fetal barrier and fullerenes were 
found to have a fatal effect on mouse embryos (Elsaesser & Howard, 2011; Stern &  
McNeil, 2008). 
When nanoparticles enter the blood vessels, or any biological fluid, e.g. saliva or mucus  
they are most likely surrounded by a layer of proteins. This dynamic protein “corona” 
depends on the concentration in the biological fluid and hence the composition of the layer 
varies in different parts of the body (Cedervall et al., 2007; Lundqvist et al., 2008; Lynch et 
al., 2007; Walczyk et al., 2010,). Thus, the reactions in the body to such a NP-protein complex 
is most likely different from that induced by the bare NP and possibly affecting bio-
distribution and thereby causing unwanted side effects (Adiseshaiah et al., 2010; 
Leszczynski 2010,).  The function of protein coating is not fully known but since most 
nanoparticles show strong affinity for proteins, it is of importance to investigate this 
interaction in different fluids. In blood, plasma proteins constituting the NP corona is 
possibly affecting a wide range of effects such as phagocytosis via immunoglobulins and 
complement (Dobrovolskaia & McNeil 2007), coagulation via prothrombin (Dobrovolskaia 
2009) and the distribution of  lipoproteins (Benderly et al., 2009; Hellstrand  et al., 2009; 
Zensi et al., 2010). 
The availability and toxicity of any substance to a biological organism is determined by both 
the concentration/dose that the organism is exposed to, as well as the “toxicokinetics” of the 
substance. These include the uptake, transport, metabolism and sequestration to different 
compartments by the organism, as well as the elimination of the substance from the 
biological organism. These parameters are essential since the potential toxicity of substances 
is dependent upon the specific organs or cell types exposed, which form the substance is in 
(e.g. bound to serum protein, aggregated, dissolved, oxidized), as well as the period of time 
the substance interacts/remains at the site of primary and secondary exposure. These 
parameters are influenced by the physical–chemical characteristics of the substance, 
therefore a detailed characterization of the substance is pivotal in order to allow 
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generalizable conclusions and should therefore be given ample attention. Furthermore, most 
of these toxicological parameters involve proteins and/or actions carried out by proteins. 
Thus it is pivotal to the understanding of NP toxicology, and thereby the possibility to 
predict health effects caused by NPs, to understand NPs interactions with proteins.  One of 
the best, if not the best, technique to separate proteins is two-dimensional gel 
electrophoresis (2-DE). Preferably, this is combined with peptide mass fingerprinting and 
MALDI-TOF MS analyses for fast identification of the separated proteins, which then may 
be followed by tandem MS analyses for sequence information. Here we present our results 
regarding serum protein interactions with metal-nanoparticles (Al2O3, ZnO/Al6%, SiO2) 
and Carbon Nanotubes, obtained using 2-DE and MS. Furthermore, we elaborate on and 
exemplify different aspects of the 2-DE/peptide mass fingerprinting-technique to further 
improve the approach. 
1.2 General introduction to the 2-DE technique 
Two-dimensional gel electrophoresis (2-DE) is an excellent method for separation of 
proteins from most kinds of tissues and complex mixtures of proteins (O`Farrel-1975). Both 
qualitative characterization of the protein expression, including post-translational 
modifications and quantitative characterization comparing the protein expression in 
different individuals or groups, are possible by this technique. Two steps are included, the 
isoelectric focusing (IEF) step, where the proteins are separated according to their isoelectric 
point (pI) in a pH-gradient, and the sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE) step, where the proteins are separated according to their 
molecular weight. Since it is less common that two proteins have the same isoelectric point 
and molecular weight, this will result in each protein migrating to its own unique position. 
The 2-DE technique allows, depending on the nature of the sample, the separation of 500-
3000 protein spots and the resolution can be improved, e.g. by removal of abundant proteins 
or by composite gels from overlapping pH-gradients. Proteins separated by gel 
electrophoresis can be visualized by a number of methods using different types of stains. 
Various stains interact differently with the proteins and some of the stains used are not even 
specific for proteins. The degree of sensitivity is also different. Processing data from stained 
protein gels by computers includes the gel images being digitized by an imaging system and 
then analyzed using computer software allowing a number of different measurements such 
as number, size, and intensity of the stained protein spots. Separated proteins are then 
identified by mass spectrometry (MS). The proteins are in-gel digested and extracted 
peptides analyzed by peptide mass fingerprinting or peptide sequencing. Two widely used 
MS instruments used for these respective analyses are matrix assisted laser 
desorption/ionization-time of flight-mass spectrometry (MALDI-TOF MS) where peptides 
are transferred from solid phase to gas phase, and electrospray ionization tandem mass 
spectrometry (ESI MS/MS) where peptides are transferred from liquid phase to gas phase. 
The key advantage with 2-DE is the ability to separate protein isoforms. On the other hand, 
very large and hydrophobic proteins are underrepresented in 2-DE and the need of peptide 
extraction from the in-gel digests may influence to amounts of analytes available for MS 
protein identification. Nevertheless, combining the separation and analytical ability of the 2-
DE technique with the identification power of MS provides a powerful tool in human 
toxicology. 
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2.1 Characterization of nanoparticles 
Commercial SiO2 size 0.007µ (S-3051), ZnO/6% Al doped <50nm(677450), and Al2O3 <50nm (544833) 
were purchased from Sigma Aldrich. As comparison, single walled Carbon Nanotubes 
(CNO, 704121) from Sigma Aldrich was used.  Nanoparticles, characterized by 
manufacturer, were dispersed in Milli-Q water and/or PBS (137 mM NaCl, 2.7 mM KCl, 
8.45 mM Na2HPO4, 1.47 mM KH2PO4 pH 7.3) and sonicated on ice for 10 min. The 
hydrodynamic sizes of the particles were analyzed by Dynamic Light Scattering (DLS).   
DLS measurements were performed using an ALV/DLS/SLS-5022F system (ALV-GmbH, 
Langen Germany) and a HeNe laser at 632.8 nm with 22 mW output power. The scattering 
angle was 90 and the temperature 22C. For temperature stabilizing purposes, samples 
were placed in a thermostat bath (22C) for at least 10 minutes prior to the measurements. 
Samples were diluted in Milli-Q water or PBS. Ultrasonication of two different kinds was 
performed to decrease the degree of agglomeration; either an ultrasonic bar homogeniser 
(Sonoplus HD 2200, Bandelin electronics, Germany) was used or samples were placed in an 
ultrasonic bath (USC300T, VWR, Sweden). The viscosity of PBS was set to 0.9782 mPa’s by 
linear interpolation between tabulated values for 20C (0.911) and 25 C (1.023) (Hackley & 
Clogston, 2007). 
Data analysis was performed using a nonlinear fit model via ALV-Regularized Fit (ALV-
Correlator Software Version 3.0. using ALV-Regularized in nonlinear fit model    
http://www.alvgmbh.de/). 
2.2 Preparation of human plasma 
Human plasma, collected in sodium citrate tubes, was prepared from three healthy 
volunteers. After cooling, the blood was centrifuged in 800g for 10 min and plasma, free 
from red blood cells, was drawn from the top of the tube.  SiO2, ZnO/6% Al doped, Al2O3   
and CNO were then exposed to three plasma samples respectively. In all nanoparticle 
exposures fresh plasma was used. 
2.3 Nanoparticle/plasma incubation 
Nanoparticles were dissolved (final concentration 2 mg/ml) in PBS and incubated with 1% 
plasma at 37˚C for 1h. As control, to ensure there was no protein precipitation, one sample 
was prepared without nanoparticles. Unbound proteins were separated from nanoparticles 
by centrifugation for 40 min at 50 000g and 4°C. The supernatant was discarded and the 
particle pellet was washed in Dithiothreitol (DTT, Sigma-Aldrich) 20mM/-acetone buffer 
followed by a second centrifugation step for 10 min at 50 000g and 4°C. The supernatant was 
discarded and the pellet was air dried. The pellets containing nanoparticles and attached 
proteins were then dissolved in denaturing solution containing 9M Urea (Sigma-Aldrich), 
65mM DTT and 4% (3-(3-cholamidopropyl)-dimethylamino)-1-propanesulfonate (CHAPS). 
The solution was incubated at room temperature for 30 min before denatured proteins were 
separated from the nanoparticles by centrifugation for 30 min at 50 000g and 4°C. The 
supernatant was collected and the samples were analyzed in triplicates.  20 µl (40µg protein) 
was applied on the IEF strip in each 2-DE analysis. 
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2.4 Isolation of lipoproteins 
2.4.1 HDL isolation 
Preparation of high density lipoprotein (HDL) was performed by a method described by 
Sattler et al.1994, with slight modifications (Karlsson et al., 2005). Blood samples in EDTA-
containing tubes were obtained from healthy volunteers after an overnight fast. After 
centrifugation (10 min, 700g) at room temperature, plasma was collected. EDTA (1 mg/mL) 
and sucrose (final concentration 0.5%) were added to prevent HDL oxidation and 
aggregation, respectively. Five milliliters of EDTA-plasma adjusted to a density of 1.24 
g/mL with solid KBr (0.3816 g/mL) was layered in the bottom of a centrifuge tube 
(Beckman, Ultraclear tube). The EDTA plasma fraction was gently overlayered with 
KBr/PBS solution (0.0834 g KBr/mL, total density 1.063 g/mL). In one centrifuge tube, 
proteins were stained with Coomassie Brilliant Blue to be used as a reference while 
collecting the HDL fraction.  Ultracentrifugation was performed in a Beckman XL-90 
equipped with a Ti 70 rotor (fixed angle; Beckman Instruments, Fullerton, CA, USA) for 4 h 
at 290 000g and 15ºC. By this procedure the lipoprotein fractions with a density lower than 
1.063 g/mL (low density and very low density lipoprotein) are located at the top of the tube 
and HDL is located in the middle of the tube. HDL was collected by penetrating the tube 
with a syringe. To avoid contamination by serum proteins, HDL were then further purified 
by a second centrifugation step. KBr/PBS solution (0.3816 g KBr/mL) was added to the 
HDL (total density 1.24 g/mL) and the centrifugation was performed under the same 
conditions as described above, but for 2 h. HDL was collected from the top of the tube and 
desalted using desalting buffer (NH4HCO3, 12mM, pH 7.1) and PD 10 columns (Sephadex™ 
G-25 M, GE Healthcare, Buckinghamshire, United Kingdom ). Protein concentration in the 
HDL solution was determined with Bio-Rad protein assay (Bio-Rad, Richmond, CA, USA). 
Sample (3.5 mL) was lyophilized and dissolved in 0.25 mL sample solution (9 M Urea, 4% 
CHAPS, 2% Pharmalyte ,  65 mM DTT, 1% bromophenol blue) according to Görg et al.1988. 
2.4.2 Immunoaffinity chromatography 
Anti-ApoA-I antibodies were attached to a 5 mL HiTrap NHS-activated HP column (GE 
Healthcare) according to manufacturer’s instructions. 2.5 mL plasma were desalted by the 
use of PD-10 columns and the eluted sample were diluted to 4 mL with 50 mM Tris-HCl, 
0.15M NaCl, pH 7.5. The ApoA-I coupled immunoaffinity column were equilibrated by 
allowing 10 column volumes flow through it. Desalted sample were applied into the column 
and allowed to recirculate for 40 minutes. Loop were disconnected and washed with 10 
column volumes of 50 mM Tris-HCl, 0.15M NaCl, pH 7.5 followed by ten column volumes 
of 50 mM Tris-HCl, 0.5M NaCl, pH 7.5. ApoA-I adsorbed to the column were eluted with 20 
mL of 0.1M Glycin-HCl, pH 2.2. Sample was collected in fractions of 0.4 mL in tubes which 
each contained 20 µL 1M Tris, pH 9.0 for pH-neutralization of the sample. Fractions 
containing proteins were pooled and desalted using PD-10 columns. 
2.5 Albumin and IgG removal  
The removal of the high abundance proteins albumin and IgG from plasma was performed 
using an Albumin and IgG removal kit (GE Healthcare). Briefly, the column was 
equilibrated with binding buffer (20mM Na2H2PO4, 0.15M NaCl, pH 7.4), 50 µl of plasma 
www.intechopen.com
 Gel Electrophoresis – Advanced Techniques 
 
332 
was diluted to a volume of 100 µl and applied to the column. After 5 min incubation, the 
depleted sample was collected in an eppendorf tube by centrifugation at 784g.  The total 
protein concentration before/after depletion was determined with Bio-Rad protein assay. 
After depletion of high abundant proteins the samples were desalted using PD-10 columns.  
2.6 2-DE analysis 
2-DE was performed using IPGphor and Multiphor (GE healthcare).  Briefly, the proteins 
were resuspended in 150 μL of a 2-DE sample buffer containing 9 M urea, 65 mM DTT, 2% 
Pharmalyte (GE Healthcare), 4% CHAPS, and 1% bromophenol blue and then centrifuged at 
4ºC and 23000g for 30 min to remove debris. The supernatant was then mixed with a 
rehydration buffer consisting of 8 M urea, 4% CHAPS, 0.5% IPG buffer 3-10 NL (GE 
Healthcare), 19 mM DTT, and 5.5 mM Orange G to a final volume of 350 μL. The first 
dimension was performed by in-gel rehydration for 12 h in 30 V on 18 cm pH 4-7 linear or 
pH 3-10 nonlinear IPG strips (Immobiline DryStrips, GE Healthcare). The proteins were then 
focused at 53000 Vh at a maximum voltage of 8000 V (Görg et al., 2000). The second 
dimension (SDS-PAGE) was performed by transferring the pI focused proteins (IPG strips) 
to homogeneous or gradient home-cast gels on gel bonds. The electrophoresis was 
performed at 40-800 V, 10°C, 20-40 mA, overnight. 
2.7 Staining and image analysis 
Sypro Ruby (Bio-Rad) staining were done according to manufacturer’s instructions. In short, 
gels to be stained with Sypro Ruby were directly placed in a fixing solution containing 10% 
methanol and 7% acetic acid for at least 20 minutes after 2-DE. Gels were then washed 3x10 
minutes under agitation with Milli-Q water before approximately 400 mL of Sypro Ruby 
stain were added and incubated in room temperature over night.  
Silver staining of gels were done according to Shevchenko et al. 1996, with some few 
modifications. Proteins were fixed by incubating the gel in 50% methanol and 5% acetic acid 
for at least 20 minutes directly after 2-DE and then incubated with 50 % Methanol for 5 
minutes, followed by Milli-Q water for 10 minutes. In the sensitizing step the gel was 
incubated with 0.02 % sodium thiosulphate for 1 minute, followed by 2x1 minutes washing 
with Milli-Q water. The gel was then immersed in 0.1 % silver nitrate solution for 20 
minutes before excess of silver was washed away by 2x1 minute in Milli-Q water. Next, the 
gel was developed in 0.04 % formaldehyde in 2 % sodium bicarbonate solution for 2x1 
minute. The exact developing time was optimized depending of the protein amount in the 
gel. Finally, the reaction was stopped by incubation 1x5 min in 0.5 % glycine and the gel 
washed with Milli-Q water for 2x20 min.     
The images of the protein patterns were analyzed by a CCD (Charge-Coupled Device) 
camera digitizing at 1340*1040 pixel resolution in a UV scanning illumination mode for 
Sypro Ruby stained gels or at 1024*1024 pixel resolution in white light mode for silver 
stained gels using a Flour-S-Multi Imager in combination with a computerized imaging 12-
bit system (PDQuest 2-D gel analysis software, version 7.1.1). The unit of the UV light 
source is expressed in counts while the unit of the white light source is expressed as optical 
density (OD). Gel images were evaluated by spot detection, spot intensities and geometric 
properties.  
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2.8 Isolation of protein spots  
Protein spots were excised from the gels using a syringe and transferred to eppendorf tubes. 
For silver destaining, 25 µL of 100 mM sodium thiosulphate and 25 μL of potassium 
ferricyanide were added to the gel pieces (Gharahdaghi et al., 1999). When the pieces were 
completely destained, the chemicals were removed by washing (6×5 min with Milli-Q 
water) before addition of 50 μL of 200 mM ammonium bicarbonate and incubation for 20 
min at room temperature. The gel pieces were washed (3x5 min with Milli-Q water) and 
dehydrated with 100% acetonitrile (ACN) for 5 min or until the gel pieces were opaque 
white. After removal of the ACN, the gel pieces were dried in a SpeedVac vacuum 
concentration system (Savant, Farmingdale, NY). Protein spots excised from Sypro Ruby 
stained gels were washed in 50% ACN/25 mM ammonium bicarbonate 2x30 min prior to 
dehydration with 100% ACN.  
2.9 Digestion 
2.9.1 Tryptic digestion 
The protein spots were excised from the gel with a syringe and transferred to small eppendorf 
tubes (0.5 mL). Proteins from fluorescently stained gels were visualized and excised on a blue 
light transluminator (DR-180 B from Clara Chemical Research, Denver, CO, USA) wearing 
darkened amber glasses. After destaining and dehydration, about 25 µL trypsin (20 mg/mL in 
25 mM ammonium bicarbonate, Promega, Madison, WI, USA) was added to each gel piece. To 
minimize autocatalytic activity, the samples were kept on ice for 30 min, prior to incubation in 
37º C over night. The supernatant was transferred to a separate tube and the peptides were 
further extracted from the gel piece by incubation in 50% ACN/5% trifluoroacetic acid (TFA, 
Sigma-Aldrich) for 5 h at room temperature. The supernatant from the two steps was then 
pooled and dried in SpeedVac until complete dryness. If not dissolved in 5 µL 0.1% TFA for 
further MS preparation, the proteins were stored at -70ºC. 
2.9.2 Glu-C digestion 
Glu-C (Roche, Basel, Switzerland) was diluted with 25 mM NH4HCO3, pH 7.8, to a 
concentration of 20 µg/mL. 25 µL was added to each gel piece and incubated at room 
temperature over night. The supernatant was then dried in SpeedVac until complete dryness. 
If not dissolved in 5 µL 0.1% TFA for further MS preparation the proteins were stored at -70ºC. 
2.9.3 Cyanobromide digestion 
One Cynobromide (CNBr, Sigma-Aldrich) crystal was dissolved in 250 µL 70% TFA (in dH2O). 
25 µL CNBr in 70% TFA was added to the dried gel piece and incubated in darkness in room 
temperature overnight. The supernatant was then dried in SpeedVac until complete dryness. If 
not dissolved in 5 µL 0.1% TFA for further MS preparation the proteins were stored at -70ºC. 
2.9.4 Endoproteinase Asp-N digestion 
Asp-N (P3303, Sigma-Aldrich) was diluted with 100 mM NH4HCO3 pH 8.5 to an enzyme 
concentration of 8 µg/mL.  25 µL was added to one tube containing one gel piece.  To 
minimize autocatalytic activity, the samples were kept on ice for 30 min, prior to incubation 
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in 37º C over night. The supernatant was then dried in SpeedVac until complete dryness. If 
not dissolved in 5 µL 0.1% TFA for further MS preparation the proteins were stored at -70ºC. 
2.9.5 Enzymatic deglycosylation 
HDL (500 µg) was lyophilized and dissolved in 100 µL 2-DE sample buffer (described 
earlier).The sample was then incubated with 20 U of PNGase F (Sigma-Aldrich, P7367) in 37˚ 
C over night. After incubation, sample were stored in -20ºC until 2-DE.   
HDL was desalted in a PD-10 column and eluted in a 50 mM Na2HPO4, pH 6.0 buffer. A 
volume corresponding to 1200 µg of HDL proteins were then incubated with 10 U of 
Neuraminidase (Sigma-Aldrich, N3786) in 37˚ C for 4 hours. After incubation, sample was 
desalted in a PD-10 column with desalting buffer (NH4HCO3, 12mM, pH 7.1) and 
subsequently frozen in -70ºC. Sample was lyophilized before 2-DE.  
2.10 ZipTip  
After digestion and drying of peptide samples, some were desalted and purified by the use 
of ZipTipC18® pipette tips (Millipore, Billerica, MA, USA). Samples were diluted up to 10 µL 
with 0.1% TFA. A ZipTip was wet by loading 3x10 µL with 50% ACN and discarding the 
liquid. Ziptip was equilibrated by loading 3x10 µL of 0.1% TFA and discarding the fluid 
before peptide sample was carefully loaded into the ZipTip by pipetting. The ZipTip was 
washed with 5x10 µL of 0.1% TFA before peptides were eluted with 10 µL 50% ACN. 
2.11 Mass spectrometry  
Peptides obtained after digestion were mixed 1:1 with matrix, ǂ-Cyano-4-hydroxycinnamic 
acid (CHCA, 0.02 mg/mL) or 2,5-dihydroxybenzoic acid (DHB, 0.02 mg/mL) in 70% 
ACN/0.3% TFA, and then spotted onto a stainless steel target plate. Analyses of peptide 
masses were performed using MALDI TOF-MS (Voyager DE PRO; Applied Biosystems) 
equipped with a 337 nm N2 laser operated in reflector mode with delayed extraction. 
Positive ionization, a delay time of 200 ns, and an accelerating voltage of 20 kV were used to 
collect spectra in the mass range of 600–3600 Da. Data processing of the spectra was 
performed in a Data Explorer TM Version 4.0 (Applied Biosystems). External mass 
calibration with a standard peptide mixture and internal calibration using known trypsin 
autolysis peaks (m/z 842.5100, 1045.5642, 2211.1046) were also performed prior to the 
database search. For tandem MS analysis, the digested peptides were dried and dissolved in 
10 µL 0.1% TFA. The peptides were desalted and purified by using ZipTipC18® columns. 
Elution was acidified by the addition of 1% formic acid. About 2 µL of the sample was 
applied into a silver-coated glass capillary and analyzed by a hybrid (triple quadrupole-
TOF) mass spectrometer (API Q-STAR Pulzer; Applied Biosystems) equipped with a 
nanoelectrospray ion source (MDS-Protana, Odense, Danmark) operated in the nanopositive 
mode. Data processing was performed with Analyst QS software (Applied Biosystems). 
Fragmentation spectra were interpreted manually. 
2.12 Database search 
Peptide masses (major peaks) in the spectra were submitted to database search. NCBI and 
Swiss-Prot were used with Aldente or MS-Fit as search engines. Restrictions were human 
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species, mass tolerance >75 ppm in most of the searches, maximum one missed cleavage, 
and cysteine modification by carbamidomethylation. MS-Digest, MS product, and BLAST 
search was used for protein identification of the derived tags resulting from amino acid 
sequencing with MS/MS. In peptide mass fingerprinting, protein matches with p-values 
below 0.05 are used and with LC-MS/MS analyses an FDR < 1 % is considered significant.  
2.13 Western blot 
Plasma proteins were separated on 2-DE. Proteins were then transferred to a 0.2 μm PVDF 
membrane. After blocking with 5% non-fat dry milk in Tris buffered saline (TBS) overnight, 
the membrane was washed two times with Tween-Tris buffered saline (TTBS, pH 7.5) and 
then incubated overnight with primary rabbit anti human C-III antibodies (Abcam, 21032, 
1:5000) in 2% non-fat dry milk in TTBS (pH 7.5) at room temperature. After washing four 
times with TTBS, the membrane was further incubated for 1h with secondary goat anti 
rabbit antibodies conjugated with horse radish peroxidase (HRP, 170-6515, BioRad,1:40 000) 
in 2% non-fat dry milk in TTBS (pH 7.5) at room temperature.  In order to visualize the 
proteins the PVDF membrane was treated with ECL Plus Western Blotting Detection System 
(GE Healthcare) and then exposed to X-ray film (AGFA Medical, Mortsel, Belgium). 
3. Results and discussion 
3.1 Nanoparticle characterization 
DLS, which is also known as Photon Correlation Spectroscopy or Quasi-Electron Light 
Scattering, is a technique used to study the size and size distribution of particles suspended 
in a liquid. The technique is based on the scattering of light of particles in diffusive random 
(brownian) motion. The average displacement for the Brownian motion is defined by the 
translational diffusion coefficient (D). The particle diffusive motion in liquid is size 
dependent, and a larger particle has a slower motion as compared to a smaller particle.  This 
brownian motion can be investigated by irradiating the sample with a coherent laser and 
studying the intensity fluctuations of the scattered light (Finsy, 1994).  
Particle sizing can be done in several ways. Typically the information retrieved from 
different techniques is to some extent diverse, as each technique is sensitive to it´s specific 
properties of the particles. That means that a technique which is based upon the scattering 
intensity does not deliver the same size or size distribution as a technique that is based upon 
the projected area or the density of a nanoparticle. For nano sized particles, transmission 
electron microscopy (TEM) is frequently used in purpose to study the size and the shape of 
particles. In TEM, the sample preparation together with the measurement is relatively time 
consuming and furthermore the measurement is limited only to a very small fraction of the 
sample. This means that a lot of replicates must be studied in order to achieve good 
statistics. A dynamic light scattering measurement on the other hand, is fast and convenient 
as it usually takes only a few minutes to perform. Data recording procedure is thus short but 
the analysis and interpretation requires knowledge and care. DLS measurements must be 
performed with highly diluted solutions, to avoid multiple scattering phenomenons and 
misleading artifacts are frequently present in DLS studies.  
Particle sizes obtained when measuring with DLS are by default larger than those obtained 
when analyzing the material with TEM. The size calculated from the translational diffusion 
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coefficient in DLS generally is referred to as the hydrodynamic diameter, e.g the diameter of 
a sphere having the same diffusion coefficient as the particle, while the size of the 
nanoparticles obtained from TEM is the core size of the nanoparticle investigated. It should 
be noted that in many cases when the sample consists of a mixture of nanoparticles with a 
range of sizes and/or mixture of particle shapes,  results should be taken as an estimation 
only but clearly trends can be observed. 
The autocorrelation function of the scattered intensity results in an average value of the 
product of the intensity at time t and the intensity at a time delay later t+dt. The value 
obtained from the correlation function is large for short delays, since the intensities are 
highly correlated.  The value will be low for longer delays; i.e. the autocorrelation can be 
described as a decaying function of time delay. From the autocorrelation function, the 
diffusion constant D can be determined. Furthermore, by using Stokes-Einstein equation the 
corresponding size distribution is calculated according to:  
 d = kBT/3πηD (1)  
where kB is the Boltzman constant, T the temperature, η the viscosity of the solvent and d 
the hydrodynamic diameter of the particles. This implies that the temperature must be 
constant during the measurement and the viscosity of the sample solvent must be known. It 
should be noted that the formula shown above (Equation 1) is valid only for non-interacting 
spherically shaped particles, i.e experimental data are fitted to a model assuming spherical 
particles (Finsy, 1994). 
Figure 1 shows five different functions representing the typical information retrieved in  
DLS in the actual measurement and by using algorithms. The measured data in DLS is  
the correlation function (Figure 1A). This function holds information about the diffusion  
of particles in the sample and can be transformed to a graph showing the decay time of  
light scattering fluctuations (Figure 1B). From the decay time distribution function, the 
values of the particle radius (Figure 1C) can be calculated using the Stokes-Einstein 
equation.  
The amount of light that is scattered from a particle is dependent on the particle size. 
According to the Rayleigh theory (Sorensen, 2008), the scattering factor roughly is 
proportional to the sixth power of the particle size. This means that a small particle scatter 
light less than a larger particle and thus different weights have to be applied to transform 
the intensity weighted data to a useful size distribution. These weights can be mass based 
(Figure 1D) or number based (Figure 1E).  Powder based samples that are dispersed in a 
liquid often are severely aggregated. Ultrasonic baths can be used to decrease the 
aggregation in the solution. Choice of solvent is also important and it clearly affects the 
capability of dispersing nanoparticles.   
A number of examples of DLS results for commercial particles are shown in Figure 2, 3 and 
4. The size distributions of Al2O3 nanoparticles , based upon number weighted fits of the 
data are shown in Figure 2. A set of samples were dispersed both in Milli-Q water and PBS.  
The size and size distribution were measured as a function of concentration. According to 
the supplier these particles are < 50 nm in size as measured by TEM, which should be taken 
as the core size of the nanocrystals in the Al2O3 material. A lot larger hydrodynamic 
diameters are achieved in our measurements, which show that the water based sample is 
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composed of at least two populations with hydrodynamic radius of about 100 nm and 200-
300 nm respectively. The smallest radius from this DLS study was achieved for Al2O3 
dispersed in Milli-Q water and ultrasonicated with a bar homogenizer (radius approx. 30 
nm). Also for samples dispersed in PBS, ultrasonication with a bar homogenizer indicates 
decrease of the aggregation and introduction of populations with smaller radius.  
 
Fig. 1. Example of the typical information retrieved in a DLS measurement.  
The measurement is performed on Al doped ZnO nanoparticles dissolved in MilliQ water.  
A) shows the correlation function which has a high correlation (close to 1)  for really short 
lag times but decays to zero  with a  rate dependent on the particle size distribution in the 
sample. B) shows the normalized distribution function of the Decay time. C) shows the 
normalized distribution of the unweighted radius and the corresponding normalized 
distributions of the mass weighted radius and the number weighted radius are shown in D) 
and E) respectively.  
Figure 3 shows the size distribution of Aluminium doped ZnO nanoparticles dispersed in 
water and PBS. Bar ultrasonication introduces smaller sized populations, in consistence with 
the results in Figure 2. The hydrodynamic radii of these particles in MilliQ water are around 
30 nm as largest according to Figure 3. This could be compared with the information from 
the supplier that these particles are < 50 nm as measured by TEM. Again hydrodynamic 
diameter is always larger that the core size of nanocrystals obtained from TEM. In this case 
the sample is also aggregated in solution, which produces even larger sizes and size 
distributions.  
The SiO2 particles are 7 nm sized as primary particles according to the supplier based on 
calculations using the surface area as measured by the nitrogen adsorption method of 
Brunauer (Brunauer et al., 1938). The supplier also states that these particles commonly form  
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Fig. 2. DLS measurements of Al2O3 nanoparticles. 
The normalized distribution of the number weighted radii of particles in Al2O3 nanopowder 
diluted to different concentrations in A) MilliQ and B) PBS as measured by DLS. As marked in 
the figure, two different kinds of ultrasonic treatment were used to decrease the aggregation 
before performing the measurement; either an ultrasonic bath or a bar homogenizer.  
 
Fig. 3. DLS measurements of ZnO (Aluminium 6% doped) nanoparticles. 
The normalized distribution of the number weighted radii of particles in ZnO (Aluminium 
6% doped) nanopowder diluted to different concentrations in A) MilliQ and B) PBS as 
measured by DLS. As marked in the figure, two different kinds of ultrasonic treatment were 
used to decrease the aggregation before performing the measurement; either an ultrasonic 
bath or a bar homogenizer.  
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some hundreds of nanometer long chainlike branched aggregates.  The size distributions 
obtained in our DLS measurements are presented in Figure 4. For all three concentrations 
in Milli-Q water the particle size is below 100 nm in radius. When SiO2 particles are 
dispersed in PBS (Figure 4B), large aggregates are definitely present, which are  
partly removed when ultrasonicated with a bar homogenizer. Multiple scattering, surface 
charge on the nanoparticles and water solubility should be considered when further 
evaluating these data. Furthermore, it is known that these specific samples (SiO2) are 
inhomogenous and the sample is thus far from ideal, i.e does not contain spherical shaped 
particles. It is shown in previous studies that long chainlike branched aggregates  
are present. 
 
Fig. 4. DLS measurements of SiO2 nanoparticles. 
The normalized distribution of the number weighted radii of particles in SiO2 nanopowder 
diluted to different concentrations in A) MilliQ and B) PBS as measured by DLS. As marked 
in the figure, two different kinds of ultrasonic treatment were used to decrease the 
aggregation before performing the measurement; either an ultrasonic bath or a bar 
homogenizer.  
In conclusion, it could be said that size and size distribution of nanoparticle samples could 
be estimated by DLS. Valuable information as the trends in size distribution connected to 
sample preparation methods and choice of solvent can be obtained. Sample preparation 
methods are indeed very important as well as choice of solvent. Care should be taken when 
choosing fitting model and the model-inbuilt parameters. Inhomogeneous samples are less 
straight forward to analyze. Presence of aggregates is easily detected. In summary 
information obtained from DLS  is important for everybody that is doing research on 
nanoparticles in liquids. The numbers given as product information i.e. the size and size 
distribution, are often relevant for the core-size of the nanocrystals within the material. 
However the nanoparticles are most often not soluble to that extent. Nanoparticles obtained 
in dry state and then dispersed in liquid usually form aggregates as shown in this study.  
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3.2 Nanoparticle-plasmaprotein interactions 
In a previous study performed by us, the inflammatory response in human monocyte derived 
macrophages after exposure to wear particles generated from the interface of studded tires 
and granite containing pavement (Karlsson et al. 2011) was investigated.  Particle 
characterization showed that dominating peaks in the EDX spectra were Silica and 
Aluminium. Particles of nanosize were also present (SMPS), but it was not possible to 
characterize them due to low abundance. As a result of their very small diameter (< 0.1 µm), 
inhaled nanoparticles are believed to be predominantly agglomerated and deposited in the 
periphery of the lungs, where they interact with cells such as macrophages and epithelial cells 
(Beck-Speier et al. 2005) but they may also translocate into the circulation, which is a critical 
step, since their fate in vivo in not known. Investigating plasma protein-nanoparticle 
interactions with a toxico-proteomic approach is a useful tool to improve our knowledge about 
the effects of nanoparticles of different origin, size and surface properties in biological systems. 
In purpose to mimic a potential exposure to airborn nanoparticles translocated into the 
circulation, commercial SiO2 and Al2O3 were mixed with plasma proteins. As comparison, 
commercial ZnO (Al-doped 6%) and a non-metal oxide; single walled Carbon Nanotubes 
was used. All preparations were performed in triplicates with three different subjects 
exposed to each type of particles. The protein patterns resulting from the three different 
exposures of commercial SiO2, Al2O3, ZnO and CNO respectively were identical.  
Particle characterization and estimation of particle agglomeration prior to exposure is 
crucial. In a recent study of nanoparticle-plasma protein interactions (Deng et al. 2009), the 
DLS spectra indicated large agglomerates prior to plasma protein exposure. Most likely, and 
in line with the authors suggestions (Deng et al. 2009), complexes with hydrodynamic size 
of 10000-100 000 nm do not result in the same protein patterns as the interactions of smaller 
particles/agglomerates and plasma proteins. In our optimized protocol, with different 
particle origin, less gentle bar sonication instead of in water bath and thereby reduced hydro 
dynamic sizes of the agglomerates (Fig 2-4) - an altered pattern of interacting proteins was 
indeed found (Figure 5, Table 1).  
Interestingly, the interaction of SiO2 and CNO with plasma proteins resulted in very similar 
protein patterns despite their different properties (Fig 5). It has to be stated though, that the 
fate of CNO in the lung may not be translocation into the circulation due to the tube like 
structure, but CNO is also of interest for medical applications (Wu et al. 2011).  
The transport proteins Albumin and Alpha-2-HS-glycoprotein interacted with SiO2, CNO and 
ZnO but not Al2O3 while Transferrin interacted with SiO2, Al2O3 and notably also CNO but not 
ZnO. Supporting our results, the binding of albumin to single walled CNO has previously 
been described to promote uptake by the scavenger receptor in RAW cells (Dutta et al., 2007). 
In line, intravenous administration of CNO has in a different study resulted in high 
localization in the liver (Cherukuri et al., 2006). Another possible way for nanoparticles into 
the cells, are as Transferrin/particle complexes that are able to enter the cells via the 
Transferrin receptor.  The Transferrin receptor is an interesting and relevant target in cancer 
research since its expression is increased in tumor cells.  In a recent study, Transferrin 
covalently attached to silica nanoparticles carrying a hydrophobic drug caused an increase in 
mortality of the targeted cancer cells compared to cells exposed to nontargeted particles and 
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free drug (Ferris et al. 2011). What demand further studies though, is the fate of the silica 
particles in a longer perspective, taken up by tumor cells as well as other cells. A third 
transport protein, the thyroxin transporting protein Transthyretin, also known to bind toxic 
components in the blood stream (Hamers et al., 2011), was found to interact with CNO and 
SiO2.  This finding confirms a previous study that pointed out that silica interaction (inhaled) 
with plasma Transthyretin is contributing to the stabilization of fibroids in rat lungs (Kim et 
al., 2005). The possible effects of CNO interaction with Transthyretin remains to be 
investigated.  
 
Fig. 5. Plasma protein binding profiles of different nanoparticles. 
Four different nanoparticles; Al2O3, CNO, ZnO (* Aluminium-doped 6%) and SiO2, were 
mixed with human plasma and isolated through ultracentrifugation. The protein contents 
were then separated by 2-DE and silver stained. Bound proteins were identified by MS as 
shown in Table 1. 
The inflammatory marker Fibrinogen was found to interact with SiO2, Al2O3 and CNO but 
interestingly not with ZnO (Fig 5). Fibrinogen binds foreign substances in the circulation 
and promotes macrophage activation - a mechanism that may result in retention of 
particle/protein complexes in the intima with accompanying cardiovascular complications 
(Shulz et al., 2005).  On the other hand, Lysozyme C, a well known anti-bacterial agent, was 
only found on Al2O3 and ZnO. Under the present condition, it was unfortunately not 
determined if the binding to ZnO occurred due to the 6% Al doping of the ZnO. Lysozyme 
has previously been found to interact with nano-TiO2 particles (Xu et al., 2010). They 
reported that the coexistence of nano-TiO2 particles and Lysozyme resulted in the transition 
of Lysozyme conformation from ǂ-helix into ǃ-sheet secondary structure and a substantial 
inactivation of Lysozyme. Moreover the ǃ-sheets are able to induce the formation of 
amyloid fibrils, a process which plays a major role in pathology.  
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Q53H26 6.7 77000 43 65 1.23e+22 
4 Fibrinogen  Ǆ Al2O3 P02679 5.4 50000 15 32 1.39e+6 




Al2O3 Q0KKI6 7.4 30000 5 32 2779 
7 Lysozyme C Al2O3, ZNO P61626 9.4 15000 7 33 12888 
8 ǂ1-AT CNO, SiO2, 
ZNO 
P01009 5.0 55000 31 63 5.36e+18 
9 Haptoglobin CNO, SiO2 P00738 5.1 46000 8 20 2115 




P02765 4.8 55000 6 14 681 
12 Transthyretin CNO, SiO2 P02766 5.4 16000 7 51 69267 
13 Ig KC CNO Q6PJF2 8.0 30000 10 55 409936 
14 ApoA-IV SiO2, ZNO P06727 5.1 45000 10 23 72729 
15 IgǄ SiO2 P01859 7.7 55000 7 23 79647 
16 IgǄ-1 chain SiO2 P01857 8.5 35000 12 40 3.74e+7 
17 Amyloid ǃA4 ZNO B4DJT9 5.2 60000 20 15 53.1 
Table 1. Identification of nanoparticle bound plasma proteins by peptide mass 
fingerprinting after 2-DE. 
The table shows identified proteins with Uniprot accession number, isoelectric point (pI), 
molecule weight (Mw), number of peptide masses matched, sequence coverage and 
MOWSE score. a Isoelectric point (pI) and  molecular weight (Mw) as estimated on gels. b 
Matched peak masses with a mass error tolerance of 75 ppm. 
Furthermore, some antigen binding proteins; IgKC, DKFZ and IgLC, were also found to 
interact with Al2O3, CNO and SiO2 but were not detectable on ZnO (Fig 5). Immunoglobulins 
are able to activate the complement system but they also often represent unspecific binding 
during protein purification caused by insufficient washing.  Our results compared to 
previous findings indicates that increased hydrodynamic size of nanoparticle agglomerates 
seems to correlate to increased amounts of immunoglobulins. Overall ZnO was not binding 
as many proteins as the other particles and may even bind less without being Al-doped but 
an interesting finding in the ZnO preparation was a protein only described on transcript 
level and highly similar to the protein Amyloid ǃ A4 precursor. This family of proteins acts 
as chelators of metal ions such as iron and zinc. They are also able to induce histidine-
bridging between beta-amyloid molecules resulting in beta-amyloid-metal aggregates and it 
has been reported that extracellular zinc-binding increases binding of heparin to Amyloid ǃ 
A4 (Uniprot 2011).  
The protease inhibitor Alpha-1-antitrypsin, was found in the CNO, SiO2 and ZnO 
preparations but not in Al2O3 while another antioxidant, Haptoglobin was found only on 
CNO and SiO2. To our knowledge, the binding of Alpha-1-antitrypsin to the nanoparticles in 
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this study has not been described previously but an increase of Haptoglobin has been 
reported in a study investigating acute phase proteins as biomarkers for predicting the 
exposure and toxicity of nanomaterials (Higashisaka et al., 2011). 
At last, the HDL associated Apo A-I, with well known anti-endotoxin activity (Henning et 
al., 2006) and receptor interaction properties was found in all preparations but was most 
abundant after SiO2 exposure.  Apo A-I may be acting as a scavenger clearing the particles 
from the blood stream via the scavenger class B-I receptor (SRBI).  The SRBI receptor is 
mainly located on the liver and plays an important role in cholesterol efflux (Verger et al., 
2011) but is also present on other cells (Mooberry et al. 2010). Apolipoproteins in general are 
of interest for the pharmaceutical industry as carriers of nanoparticle bound drugs for brain 
uptake (Kreuter et al., 2005) since apo E and apo B-100 are taken up by the cells via receptor 
mediated endocytosis. The hypothesis is that the nano-particle/apolipoprotein complex 
mimics the natural lipoprotein particle. The identity of Apo A-I was, as the other proteins, 
confirmed by peptide mass fingerprinting using MALDI TOF MS (Table 1) and one 
dominating Apo A-I peptide in the MS spectra (Figure 6A) was in addition sequenced by 
MS/MS (Figure 6B) to further confirm the identity.  
 
Fig. 6. Identification of nanoparticle bound apoliprotein A-I with mass spectrometry after  
2-DE. 
A: Peptide mass fingerprint spectrum obtained by MALDI-TOF mass spectrometry after 
endoproteinase GluC digestion. Asterisks represent peaks corresponding to peptide masses 
of apo A-I. B: Sequencing of a triply charged peptide (m/z 409.9) corresponding to position 
194-203 of apo A-I by collision induced disassociation (CID) in a tandem mass spectrometer. 
The amino acid sequence with ions corresponding to the different fragments is shown in the 
upper right corner.  
Overall the binding of plasma proteins to nanoparticles, based on previous and our 
findings, seems to vary with origin, surface properties, size and thereby also diameter of 
agglomerates. Particle characterization prior to exposure for plasma proteins or cells is 
therefore extremely important to receive reliable results that are possible to interpret. 
Interacting proteins under the present conditions are dominated by proteins involved in the 
immune defense and reverse transport to the liver but notably also proteins mediating brain 
uptake.  
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4. Methodological considerations and improvements of 2-DE and  
MALDI-TOF MS  
4.1 Plasma sample preparations 
Sample preparation is an important step that influences the separation of proteins with 2-
DE. A common problem in most biological samples is the presence of salt ions. In 2-DE, salt 
concentrations >10 mM affects the isoelectric focusing step and markedly reduces the 
effectiveness of the charge separation. There are several easy ways to remove salts, e.g. by 
precipitation of the proteins or by gelfiltration in small desalting columns. Plasma samples 
are possible to analyze directly with 2-DE since the high protein concentration allows a 
simple dilution of the sample to lower the salt concentration. However, as illustrated in 
figure 7, a desalting step besides the dilution still improves the protein pattern. Another 
well-known problem with biological fluids is the presence of a few highly abundant 
proteins that may prevail over the low abundant proteins. In plasma, albumin and 
immunoglobulin G (IgG) constitutes a very large proportion (about 75%) of the total protein 
loaded on the gels. This may lead to the proportion of low abundant proteins being below 
the detection limit. Also, the staining of the abundant proteins may interfere with proteins 
with similar molecular mass and pI. It is therefore advisable to remove albumin and IgG 
and there are several commercial removal kits available, usually based on antibodies 
directed towards albumin and IgG. As shown in figure 7, such sample preparation step 
removes a large fraction of these proteins and increases the proportion of the other proteins 
in the sample. However, it is important to realize that this step also introduces unspecific 
removal of proteins and it is our experience that this unwanted loss of proteins varies 
considerable between the different available removal kits.  
 
Fig. 7. Preparation of plasma for 2-DE  
Untreated plasma (left), desalted plasma (middle) and desalted plasma after removal of 
albumin and immunoglobulin G (IgG), (right), were separated with 2-DE and silver stained. 
Arrows indicate protein or protein clusters with increased abundance after treatment 
compared to untreated plasma. The rectangle indicate an area with improved resolution 
after desalting. Positions for albumin and IgG chains are indicated with rings. 
Plasma contains a wide variety of proteins, many of which are not detectable with 2-DE 
without further fractionation. In view of the lipid metabolism, important sub-fractions of 
plasma to study are the lipoproteins. As shown in table 1, one protein that interacts with 
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nanoparticles is apo A-I, the major constituent of HDL. This implicates the need of more 
investigations of HDL as a possible target of nanoparticles that may influence the cholesterol 
metabolism and increase the risk of cardiovascular disease. HDL can be isolated based on 
density, size or protein content (e.g. apo A-I) using ultracentrifugation, size-exclusion 
chromatography or immune-affinity chromatography, respectively, each technique with its 
own merits and drawbacks. Thus, the rather harsh conditions during ultracentrifugation in 
high salt gradients may remove weakly associated proteins while the rather mild conditions 
during chromatography may favor unspecific co-purification of proteins with the 
cholesterol particle. We have previously mapped the protein content of HDL isolated by 
two-step density gradient ultracentrifugation (Karlsson et al., 2005). In this study we have 
compared ultracentrifugation and anti-apo A-I affinity chromatography to isolate HDL from 
the same plasma sample. As shown in figure 8, more proteins were obviously identified in 
immune-affinity purified HDL. However, some of the proteins must be considered as 
possible plasma contaminants as they were not, as e.g. the apolipoproteins, enriched in the 
HDL fraction. 
 
Fig. 8. Subfractionation of plasma with regard to HDL 
Plasma (left), HDL purified according to apo A-I with immunoaffinity chromatography 
(middle) and HDL isolated according to density with ultracentrifugation (right) were 
separated with 2-DE and silver stained. Proteins were identified with mass spectrometry.  
4.2 Protein detection 
Gel-separated proteins can be visualized by several commonly used staining methods, 
including dyes (e.g. Coomassie Brilliant Blue and colloidal Coomassie), metals (e.g. silver 
staining) and fluorescent probes (e.g. Sypro staining and Cy-dyes) (Rabilloud, 2000). The 
stains interact differently with the proteins and have different limitations with regard to 
sensitivity, linear range, compatibility with mass spectrometry and type of proteins that 
stain best. In general, for staining of complex protein samples, silver staining can be 
considered the most sensitive technique (1-5 ng protein) and Coomassie Brilliant blue the 
least (50-100 ng) while the sensitivity of colloidal coomassie and the fluorescent dyes are in 
between. However, it is important to bear in mind that the different stains interact 
differently with the proteins and therefore one protein may stain very well with one staining 
method but not with the other (Fig. 9). For example, silver ions react with negatively 
charged groups and therefore stain glycoproteins containing negative sialic acid very well. 
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One the contrary, Sypro ruby that binds to proteins through hydrophobic interactions stains 
hydrophilic glycoproteins quite poorly. Being most sensitive, silver staining is obviously very 
useful for proteomic approaches. However, the advantage with silver is hampered by its 
rather low linear range, making it less suitable for quantification than the other staining 
techniques. For plasma analyses we have therefore adopted a double staining strategy. As 
illustrated in figure 9, the 2-DE gel is first stained with Sypro Ruby and the proteins are 
quantified within a high dynamic range. The gel then can be destained and restained by silver 
to detect additional proteins. As these additional proteins are less abundant their intensities 
usually are within the limited linear range of the silver staining technique. The proteins may 
then be selected for MS analyses. As the sample preparation protocol is more time-consuming 
for silver stained gels than Sypro stained gels it is convenient to pick as many proteins as 
possible after the first staining step. In this step it is also important to check the optimal 
destaining time before MS analyses, with plasma samples at least 90 minutes (fig 9). If the 
samples are not fully destained the signal to noise in the spectra are reduced.  
 
Fig. 9. Double staining of proteins  
Plasma proteins were separated with 2-DE and first stained with Sypro Ruby. The gel was 
then destained with 25 mM ammonium bicarbonate/50 % acetonitrile buffer and the 
efficiency of the process checked after different time intervals.  Finally, the proteins were re-
stained with silver. A: Proteins more stained by Sypro compared to silver. B: Glycoproteins 
more stained by silver. The rectangle shows an area containing additional proteins detected 
by silver.  Residual Sypro staining of proteins after destaining are indicated with rings.  
4.3 Protein identification with peptide mass fingerprinting using MALDI-TOF MS 
Peptide mass fingerprinting with MALDI-TOF MS is an excellent and robust technique for 
fast identification of plasma proteins after 2-DE (Lahm & Langen, 2000). However, several 
peptide peaks needs to be detected in the spectra with a high mass accuracy to avoid false 
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positive results. There are several approaches to consider for improving the data from the 
analyses, such as digestion protocol, purification of peptides and choice of matrix. 
4.3.1 Alternative digestion of samples 
One of the most widely used ways to digest proteins before MS analyses is by trypsin, 
which cleaves C-terminally of lysine and arginine (not followed by proline). Although lysine 
and arginine often are distributed in the protein sequences in a way that provides sufficient 
number of peptides for identification after trypsin cleavage, this is not always so. 
Furthermore, it is sometimes necessary to use alternative digestion protocols in order to find 
specific peptides to e.g. characterize differences between protein isoforms. In these cases 
alternative enzymes, e.g. Asp-N (cleaves N-terminally of aspartic acid and cystein), Glu-C 
(C-terminally of glutamic acid) or chemical induced cleavage by CNBr that hydrolyzes C-
terminally of methionine, is needed. In this study we used Asp-N as a complement to 
trypsin when identifying the plasma protein serum amyloid A4 (SAA4). This combined 
digestion approach generated almost 95 % sequence coverage of the protein (figure 10). 
SAA4 is a constitutively expressed protein which can be found in HDL as differently 
charged isoforms (fig 14, Karlsson et al., 2005). One explanation to these isoforms could be a 
small truncation of SAA4 in which one lysine and one tyrosine is removed C-terminally and 
thereby making the protein more acidic (Farwig et al., 2005). However, by using Asp-N we 
were able to detect both the intact C-terminal and the intact N-terminal peptide that were 
not possible after trypsin digestion, ruling out the presence of truncated SAA4 in our sample 
(figure 10). Besides the use of Asp-N to study SAA4, we have also used Glu-C to analyze 
apolipoprotein A-I (figure 6) and CNBr to study serum amyloid A-1/2 isoforms (figure 13).     
 
Fig. 10. Alternative digestion to improve sequence coverage of Serum amyloid A4 (SAA4).  
Sequence coverage obtained through peptide mass fingerprinting with MALDI-TOF mass 
spectrometry by the use of trypsin and endoproteinase Asp-N as indicated by the lines. 
Sequence coverage (without the signal peptide in position 1-18) was 79.5 % with trypsin and 
57.1 % with Asp-N. The combined sequence coverage was 93.8%. 
4.3.2 Peptide sample cleaning 
Peptide samples after in-gel digestion can be cleaned by adsorption to C-18 containing 
pipette tips (ZipTip®). This clean-up procedure done manually is rather time-consuming 
but is absolutely necessary before electrospray-quadrupole MS. On the other hand, with a 
MALDI-TOF instrument, being more insensitive to salts and other contaminants, it is not 
that obvious. To investigate the possible advantage with ziptip cleaning before MALDI-TOF 
MS we picked 17 sypro stained proteins after 2-DE. The proteins were digested with trypsin 
and an aliquot of the obtained peptide solution was purified by ZipTip® (50% ACN elution 
solution according to the protocol recommended by the supplier), mixed with the matrix 
CHCA and spotted on the MALDI-target plate and another aliquot of the peptide solution 
was mixed directly with the matrix and spotted on the same plate. All samples were then 
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analyzed with MALDI-TOF MS with the same settings and with the laser induced collection 
of spectra in an automatic mode. The spectra were then used for NCBI database search with 
MS-fit using the same settings for all samples. All 17 proteins were identified with peptide 
mass fingerprinting in both ziptip cleaned and untreated samples. As shown in Table 2, 
ziptip cleaning significantly improved the peak intensities, signal to noise ratio and the mass 
accuracy. This illustrates that removal of salts and other contaminants that will compete 
with the peptides in the spectra increases the intensities of the peptide peaks and thereby 
increases the accuracy of the mass determinations and, as a consequence, also increases the 
reliability of the identifications. On the other hand, the number of peptides and sequence 
coverage found in ziptip cleaned samples were about the same as in the untreated samples 
(Table 2). In general, there was a clear tendency that in ziptip cleaned samples more 
peptides were detected in the lower mass region (<1000 m/z) while fewer peptides were 
detected in the higher mass region (>2000 m/z). This suggests that the removal of salt ions 
and low molecular chemicals with subsequent improved signal to noise increases the 
possibility to detect low molecular mass peptides but that this beneficial effect is 
counteracted by adsorption of larger peptides to the solid phase of the ziptip. To test this, 10 
protein samples were sequential eluted from the ziptip with increasing ACN concentration, 
up to 90 %. Indeed, this procedure increased the number of peptides found and the 
sequence coverage increased from 52 +/- 16 % in the untreated samples to 58 +/- 16 in the 
ziptip cleaned samples (p<0.05). The effect varied among the different proteins but was in 
some samples quite profound, almost 2 times higher sequence coverage. It can be concluded 
from these experiments that purification of peptide samples with ziptip improves the results 
with MALDI-TOF MS. However, when it comes to the identification of proteins with 
peptide mass fingerprinting the beneficial effect of the cleaning procedure is quite limited as 
the number of peptides found, using the standard protocol, is not increased. Therefore, 
considering the work-load needed for the ziptip procedure, it is doubtful if it is practical to 
routinely clean samples with ziptip before MALDI-TOF analyses. However, for selected, 
low abundant, samples it can most likely make a significant difference for the identification. 
In these cases, sequential elution of the peptides from the ziptip with increasing acetonitrile 














11.2 +/- 3.6 24.9 +/- 12.0 8 +/- 4 100 +/- 130 3500 +/- 2000 
Ziptip (n=17) 7.9 +/- 4.4 24.1 +/- 11.4 8 +/- 3 200 +/- 480 6300 +/- 4000 
Statistical 
significance 
0.01 No No <0.001 <0.001 
Table 2. Influence of sample cleanup of in-gel digested proteins on peptide mass 
fingerprinting data obtained with MALDI-TOF MS. 
Proteins were separated by 2-DE and in-gel digested by trypsin. The same peptide samples 
were then purified by ZipTip, mixed with the matrix and spotted on the MALDI plate or 
directly mixed with the matrix and spotted on the plate. Statistical interpretations were done 
by Wilcoxons signed rank sum test. 
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4.3.3 Choice of matrix 
To enhance the quality of the MALDI-TOF mass spectra and the number of desorbed 
peptides there are several matrices that could be considered to use. Different matrix 
compounds, both acidic and basic, have proved to work in sample preparation for MALDI 
mass analyzers. The far most commonly used matrix for peptide mass fingerprinting is 
CHCA, which is recommended for peptides with mass ions below 2500 Da (Beavis et al., 
1992). Alternative matrices also used are sinapinic acid, mostly for masses higher than 25 
kDa (Lewis et al., 2000) and DHB, originally suggested for glyco- or phosphopepides that 
are difficult to ionize (Strupat et al., 1991), but later also proven useful for silver stained 
proteins (Ghafouri et al., 2007). As illustrated in figure 11, CHCA and DHB have very 
different crystal structures on the target plate. Whereas CHCA usually has a 
homogeneously distributed spot appearance, making it ideal for automatic laser induced 
peptide desorption, the DHB crystals are needle shaped and often aggregated into fan-like 
structures directed from the outside towards the centre of the sample spot. Interestingly, we 
have found that peptides appear to be enriched in the base of the DHB structures (figure 11), 
significantly increasing the signal to noise ratio in spectra obtained from these areas. This is 
illustrated by the identification of transthyretin, one of the proteins that interact with silica 
nanoparticles and carbon nanotubes (figure 5). With DHB, the improved signal to noise in 
the spectrum displayed twice the number of peptides than with CHCA (figure 12). This 
dramatically increased the sequence coverage from 39 % obtained with CHCA to 72 % 
obtained with DHB. Thus, the use of DHB for low-abundant silver stained proteins from 2-
DE is recommended. 
 
Fig. 11. Crystals of ǂ-cyano-4-hydroxycinnamic acid (CHCA) and 2,5-dihydroxybenzoic acid 
(DHB). 
A; CHCA and B; DHB as matrix on a MALDI plate.  The marked area indicates the position 
of the laser where the best signal to noise was obtained with DHB. 
4.4 Separation and characterization of isoforms 
One of the main challenges for human proteomics is to identify and characterize co- and 
post-translational modifications to be able to study their relevance and place in systems 
biology. Most human proteins are expressed as different isoforms often depending on post-
translational modifications. Two common modifications in plasma are truncations and 
glycosylations and here we have used the ability of 2-DE to separate such isoforms based on 
differences in isoelectric point and molecular mass.  
www.intechopen.com




Fig. 12. Comparison of ǂ-cyano-4-hydroxycinnamic acid (CHCA) and 2,5-dihydroxybenzoic 
acid (DHB) as matrices in MALDI-TOF MS of a silver stained protein.  
Transthyretin was identified with sequence coverage of 39 % with CHCA (A) versus 72 % 
with DHB (B). Peptide peaks marked with an asterisk were matched to the theoretical 
masses with an accuracy <50 ppm. 
Serum amyloid A1 and A2 (SAA1 and SAA2, respectively) are two acute phase proteins, 
which share more than 95 % sequence identity. Both SAA1 and SAA2 can also be expressed as 
an alpha- and a beta-form, which are discriminated from the others only in one amino acid 
position (Strachan et al., 1989). SAA1 and SAA2 are associated to HDL (Karlsson et al., 2005) 
and are heavily induced by endotoxins (Levels et al., 2011), which is highly relevant in particle 
toxicology to discriminate between different environmental agents (Karlsson et al. 2011). Based 
on differences in isoelectric points we were able to separate four isoforms of SAA1/2 in HDL 
(figure 13A). By peptide mass fingerprinting after trypsin digestion we identified two of the 
isoforms as SAA1 with pI 5.5 and 6 and two as SAA2 with pI  7 and 8 (figures 13A and 13B). 
The theoretical pI of SAA1 and SAA2 is 5.9 and 8.3, respectively. Thus, the pI of one of the 
isoforms of SAA1 and of SAA2 corresponded to the theoretical values while the other two had 
an acidic shift (pI 6→5.5 in SAA1 and pI 8→7 in SAA2). N-terminal truncations of SAA1 
and SAA2 that would produce such acidic shifts have previously been described (Ducret et al., 
1996) and we therefore focused the MS analyses on the N-terminal peptide. As SAA1 and 
SAA2 contain arginine at the N-terminus we used CNBr, which cleaves before methionines, as 
an alternative digestion agent to detect the full length N-terminal peptide. These analyses 
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showed that the more acidic isoforms of SAA1 and SAA2 comprised a mixture of truncations 
with the loss of one, two or four amino acids N-terminally; des-Arg, des-Arg-Ser and des-Arg-
Ser-Phe-Phe, respectively, with the loss of arginine being the main explanation to the acidic 
shifts (figure 13D). On the other hand, the native peptide was only found in the more basic 
isoforms of SAA1 and SAA2. In total, four forms of SAA1 and four forms of SAA2 was 
identified. Interestingly, studies of these small molecular mass variants of SAA1 and SAA2 
with SELDI-TOF MS indicates population cluster differences in HDL related to the truncations 
in response to endotoxin (Levels et al., 2011).  
 
Fig. 13. Identification of serum amyloid A isoforms by 2-DE and MALDI-TOF MS.  
A: HDL proteins were separated by 2-DE and stained by Sypro Ruby. Arrows indicate the 
two isoforms of serum amyloid A1 (SAA1) and the two isoforms of serum amyloid A2 
(SAA2) identified by peptide mass fingerprinting. B and C: MS spectra after trypsin 
digestion of SAA1and SAA2, respectively, with specific masses indicated. D: MS spectra 
after CNBr digestion of SAA1. Masses corresponding peptides from N-terminal truncated 
variants of the protein (protein spot 1) and the mass corresponding to the N-terminal 
peptide of the native protein (protein spot 2) are indicated.  
2-DE makes it possible to separate proteins based on the degree of glycosylation. 
Hydrophilic sugars affect the binding of SDS and usually render the proteins an apparent 
higher molecular mass in the second dimension and the presence of negative sialyl-groups 
makes the proteins more acidic in the first dimension. We have therefore adapted two 
simple 2-DE mobility shift assays to demonstrate glycosylation of proteins and applied these 
to study glycosylated isoforms of plasma proteins in HDL. In the first we use 
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endoglycosidase PNGase to cleave N-linked oligosaccharides from the protein backbone 
and the second is based on enzymatic removal of sialic acid with neuraminidase. As shown 
in figure 14A, SAA4 is usually expressed in HDL as 6 isoforms, three with molecular masses 
about 18k and three with molecular masses about 11k. After PNGase treatment it was 
clearly shown that the 18k isoforms are depending on N-linked glycosylation (Fig 14A). 
Another glycosylated protein in HDL is apo C-III that can be found as three isoforms; one 
di-sialylated, one mono-sialylated and one minor non-sialylated form (Bruneel et al., 2008). 
This was demonstrated by treatment with neuraminidase, which induced a mobility shift 
with the loss of the two sialylated isoforms and a substantial increase of the non-sialyated 
apo C-III form (figure 14B).     
 
Fig. 14. 2-DE mass and charge mobility shift assays to demonstrate glycosylated protein 
isoforms.  
A: SAA4 analyzed by 2-DE and silver stained. N-linked glycosylated serum amyloid A4 
(SAA4) isoforms shown by deglycosylation with PNGase. B: Apo C-III analyzed by 2-DE 
and Western blots. Sialylated apo C-III isoforms shown by desialylation with 
neuraminidase.  
5. Conclusions and future research 
Overall the binding of plasma proteins to nanoparticles, based on our findings, seems to 
vary with origin, surface properties and size of the particles. A large portion of the 
interacting proteins we identified by 2-DE/MS are proteins involved in the immune defense 
and reverse cholesterol transport to the liver, but we also identified proteins mediating brain 
uptake. Most likely these protein patterns of the nanoparticles represent a mixture of 
particle-protein and protein-protein interactions. Extensive research in this field is therefore 
needed before conclusions could be drawn regarding potential health effects of 
nanoparticles and their associated protein “corona”. One major difficulty to overcome is 
how to characterize the particles used in different studies in such a way that comparisons 
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and generalized conclusions are allowed. Most types of nanoparticles seem to form 
aggregates, especially so in water suspensions and the “corona” seen might be heavily 
influenced by the size/diameter of these aggregates rather than by other particle 
characteristics. Thus, characterization of particles and the aggregates they form prior to 
exposure of plasma proteins, cells or other biological systems is therefore extremely 
important. One way of doing that, as we have showed herein, is by DLS. These analyses 
gives valuable information about the trends in size distribution connected to sample 
preparation methods and choice of solvent. Sample preparation methods are indeed very 
important as well as choice of solvent and care should be taken when choosing fitting model 
and the model-inbuilt parameters. Thus, information obtained from DLS is important for 
everybody that is doing research on nanoparticles in liquids. The numbers given as product 
information i.e. the size and size distribution are often relevant for the core-size of the 
nanocrystals within the material. However the nanoparticles are most often not soluble to 
that extent. Consequently, nanoparticles obtained in dry state and then dispersed in liquid 
usually form aggregates as shown in this study.  
Given ample attention to the characterization of the NPs used, future studies of the NP–
protein complex behavior in different biological systems are needed. Questions that need to 
be addressed are which properties of the NPs that govern the protein “corona” formed 
around the NPs in biological fluids and how these complexes interact with endothelial cells, 
platelets, cells of the immune system etc. One interesting finding in this study is Amyloid ǃ 
A4, not previously identified in plasma, which was only associated to ZnO particles. This 
protein may act as a chelator forming metal-amyloid aggregates and needs further attention 
in toxicological studies.  
In summary, the improved 2-DE/MS protocols shown herein underline this proteomic 
approach as a powerful tool in human nano-particle toxicology. Furthermore, thorough 
characterisation of the particles studied, e.g. with DLS, is crucial to evaluate the results. 
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